Lyell Immunopharma Inc (LYEL) earnings · rev $36.0K
These earnings events as JSON? API free 100/dayLyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
This LYEL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LYEL revenue for 2025-12-31 was $36.0K. Net income was -$274.4M. Revenue was down 41.0% from 2024-12-31 to 2025-12-31. LYEL currently screens at market cap $143.5M.
When the next LYEL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 41.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LYEL research stays on the stock page; the tape stays on the quote page.
LYEL earnings FAQ
What are LYEL's latest revenue and net income?
Latest cached Lyell Immunopharma Inc (LYEL) revenue for Dec 31, 2025 was $36.0K. Net income was -$274.4M. Statements: https://lician.com/financials/lyel
What is LYEL's latest diluted EPS?
Latest cached Lyell Immunopharma Inc (LYEL) diluted EPS for Dec 31, 2025 was -$16.06.
What period does the latest LYEL earnings print cover?
The latest cached Lyell Immunopharma Inc (LYEL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LYEL revenue change from the prior cached period?
Cached Lyell Immunopharma Inc (LYEL) revenue was down 41.0% from $61.0K (Dec 31, 2024) to $36.0K (Dec 31, 2025). Statements: https://lician.com/financials/lyel
Where are LYEL earnings listed?
Cached earnings facts for Lyell Immunopharma Inc (LYEL) are listed at https://lician.com/earnings/lyel. Statements: https://lician.com/financials/lyel
Not investment advice.